ht – Übersetzung – Keybot-Wörterbuch

Spacer TTN Translation Network TTN TTN Login Français English Spacer Help
Ausgangssprachen Zielsprachen
Keybot 124 Ergebnisse  www.menopauseandu.ca
  Mode de vie - FAQ - mam...  
L’hormonothérapie (HT) est-elle conseillée lorsqu’il existe des antécédents de problèmes cardiovasculaires?
Is hormone therapy advised where there is a history of cardiovascular problems?
  Suis-je en ménopause? -...  
À ce jour, les données demeurent floues quant aux effets de l’hormonothérapie sur les troubles oculaires. L’HT présente, toutefois, une efficacité éprouvée en matière de prévention de la douleur dentaire et d’atténuation de la mobilité dentaire et des poches parodontales.
As part of the natural aging process and due to hormonal fluctuations, women experience changes in eye function. To date, evidence is unclear about the effects of hormone therapy on eye disorders. HT has, however, proven effective in preventing dental pain, and decreasing tooth mobility and periodontal pockets. That said, HT is not recommended solely as a treatment for oral health difficulties.
  Ostéoporose - FAQ - mam...  
La Conférence canadienne de consensus de la SOGC ne recommande toutefois pas l’HT comme thérapie de première ligne pour l’ostéoporose, mais l’HT peut être recommandée pour certaines personnes présentant des symptômes de la ménopause.
Even short-term hormone therapy (HT) can improve a women’s bone structure, and then other medications can be used to sustain bone health over the longer-term. The Women’s Health Initiative in the United States, a randomized clinical trial involving menopausal women, found that hormone therapy was clearly effective in the prevention of hip fractures, vertebral breaks and other injuries. The SOGC Consensus Report, however, does not recommend HT as a first line therapy for osteoporosis, but HT may be recommended for certain individuals with the disease.
  FAQ - mamenopause.ca  
Explorez cette section de la Foire aux questions (FAQ) portant sur tout : les symptômes courants (et pas très courants!), les modifications au mode de vie qui font une différence, la santé de la vessie, la santé sexuelle, les préoccupations sur le cancer et l’ostéoporose, et bien sûr, tout ce que vous devez savoir sur les risques et les bienfaits liés à l’hormonothérapie (HT).
Explore this section of Frequently Asked Questions (FAQs) covering everything from common (and not-so-common!) symptoms, lifestyle adjustments that make a difference, bladder and sexual health, concerns about cancer and osteoporosis, and of course, everything you need to know about the risks and benefits associated with hormone therapy (HT). And all the answers are evidence-based on science and research, so you know it’s information you can trust.
  Hormonothérapie - menop...  
L’utilisation à court terme de l’HT (jusqu’à concurrence de cinq ans) constitue une option sûre et efficace pour le traitement des symptômes ménopausiques allant de modérés à graves, tels que les bouffées de chaleur, les sueurs nocturnes les sautes d’humeur, l’insomnie, les troubles de la concentration et la sécheresse vaginale.
HT is a safe and effective option for short-term use (up to five years) for the treatment of moderate to severe menopausal symptoms such as hot flashes, night sweats, mood swings, insomnia, difficulty concentrating and vaginal dryness. In addition, HT has the secondary benefit of providing protection against osteoporosis and colon cancer.
  Hormonothérapie - menop...  
Certains effets indésirables peuvent se manifester chez les femmes qui prennent une HT. Quarante pour cent des femmes subissant un traitement à l’HT connaissent une métrorragie irrégulière au cours des trois à six premiers mois.
Certain side effects can occur in women who take HT. Forty percent of women undergoing HT treatment have irregular breakthrough bleeding during the first three to six months. In most cases bleeding stops within 12 months, but for some women it may continue beyond a year. Women taking estrogen therapy may experience breast tenderness, nausea, headache and bloating. These symptoms can often be treated by changing the dosage. HT may not mix well with certain other drugs. Any woman taking HT should consult a health-care provider about drug interactions.
  Suis-je en ménopause? -...  
À ce jour, les données demeurent floues quant aux effets de l’hormonothérapie sur les troubles oculaires. L’HT présente, toutefois, une efficacité éprouvée en matière de prévention de la douleur dentaire et d’atténuation de la mobilité dentaire et des poches parodontales.
As part of the natural aging process and due to hormonal fluctuations, women experience changes in eye function. To date, evidence is unclear about the effects of hormone therapy on eye disorders. HT has, however, proven effective in preventing dental pain, and decreasing tooth mobility and periodontal pockets. That said, HT is not recommended solely as a treatment for oral health difficulties.
  Hormonothérapie - menop...  
Selon la Mise à jour sur la ménopause et l’ostéoporose (2009)de la SOGC, l’HT constitue une option sûre et efficace pour le traitement des symptômes ménopausiques allant de modérés à graves, tels que les bouffés de chaleur, les sueurs nocturnes, les sautes d’humeur, l’insomnie, les troubles de la concentration et la sécheresse vaginale.
According to the SOGC’s Menopause and Osteoporosis Update 2009 , HT is a safe and effective treatment option for moderate to severe menopausal symptoms such as hot flashes, night sweats, mood swings, insomnia, difficulty concentrating and vaginal dryness. The Consensus Report, which was produced by a team of health professionals that examined current research on menopause and the management of menopause symptoms, specifically advises that:
  Santé sexualle - FAQ - ...  
Étant donné la baisse des niveaux d’hormone au cours de cette période de la vie, il peut souvent y avoir un effet direct sur les tissus, les muscles, les glandes et les fonctions vaginales et urinaires. La sécheresse vaginale peut être un symptôme de la ménopause, même pour les femmes traitées au moyen de l’hormonothérapie (HT).
As hormone levels decline at this time of life, there can often be a direct impact on the tissues, muscles, glands and functions of the vagina and urinary tract. Vaginal dryness can be a menopause symptom, even for women receiving hormone therapy (HT). There are a variety of over-the-counter lubricating products available to help with this condition, along with vaginal estrogen creams that a physician can prescribe. If dryness worsens and leads to pain or discomfort, you should consult a physician or health professional. For more information, visit www.thebigow.ca
  Hormonothérapie - menop...  
L’hormonothérapie (HT) est parfois prescrite pour rehausser le niveau d’hormones et offrir un certain soulagement. Comme l’hormonothérapie a fait l’objet d’une grande controverse, bon nombre de femmes se demandent si elle constitue une bonne option pour elle.
Hormone therapy (HT) is sometimes prescribed to boost hormone levels and provide relief. Because it has been the subject of some controversy, many women wonder if HT is a good option for them. The Menopause and Osteoporosis Update 2009 published by SOGC recommends that doctors prescribe HT in the lowest dose required, and for the duration necessary, to treat troubling menopause symptoms. Current research confirms that HT is both a safe and effective way to treat symptoms of menopause. Your health-care provider can help you understand the risks and benefits of different treatments.
  Hormonothérapie - menop...  
D’autres HT sont appliquées directement sur la zone problématique, par exemple une crème, un comprimé ou un anneau peut être recommandé pour prendre en charge les symptômes vaginaux et restaurer le niveau d’œstrogènes.
Hormone therapies can involve oral medications, skin patches (transdermal), or gels to address symptoms such as hot flashes. Other HTs are applied directly to problem areas; for example, a cream, tablet or ring may be recommended to deal with vaginal symptoms and restore estrogen. Your physician can help advise you on HT options, as well as alternative therapies, and the impact of lifestyle choices (such as diet, exercise, and consumption of alcohol, tobacco and caffeine) on your symptoms.
  Hormonothérapie - menop...  
L’HT combinée est associée à une baisse du risque de cancer colorectal et peut légèrement accroître le risque de cancer de l’ovaire. Ces effets sont faibles et ne devraient pas influencer la décision d’une femme quant à l’utilisation de l’HT.
Combined HT is associated with a reduced risk of colorectal cancer and may slightly increase the risk of ovarian cancer. These effects are rare and should not influence a woman’s decision about the use of HT. Women who have undergone a hysterectomy and no longer have a uterus are typically prescribed estrogen therapy (ET), while other women are more likely to be given EPT (a combination of estrogen and progestin). Progestin offers the added advantage of protecting the uterus’ lining from endometrial cancers. For women with premature ovarian failure, long-term HT can help manage certain health concerns.
  Hormonothérapie - menop...  
D’autres HT sont appliquées directement sur la zone problématique, par exemple une crème, un comprimé ou un anneau peut être recommandé pour prendre en charge les symptômes vaginaux et restaurer le niveau d’œstrogènes.
Hormone therapies can involve oral medications, skin patches (transdermal), or gels to address symptoms such as hot flashes. Other HTs are applied directly to problem areas; for example, a cream, tablet or ring may be recommended to deal with vaginal symptoms and restore estrogen. Your physician can help advise you on HT options, as well as alternative therapies, and the impact of lifestyle choices (such as diet, exercise, and consumption of alcohol, tobacco and caffeine) on your symptoms.
  Hormonothérapie - menop...  
Certains effets indésirables peuvent se manifester chez les femmes qui prennent une HT. Quarante pour cent des femmes subissant un traitement à l’HT connaissent une métrorragie irrégulière au cours des trois à six premiers mois.
Certain side effects can occur in women who take HT. Forty percent of women undergoing HT treatment have irregular breakthrough bleeding during the first three to six months. In most cases bleeding stops within 12 months, but for some women it may continue beyond a year. Women taking estrogen therapy may experience breast tenderness, nausea, headache and bloating. These symptoms can often be treated by changing the dosage. HT may not mix well with certain other drugs. Any woman taking HT should consult a health-care provider about drug interactions.
  Hormonothérapie - menop...  
Certains effets indésirables peuvent se manifester chez les femmes qui prennent une HT. Quarante pour cent des femmes subissant un traitement à l’HT connaissent une métrorragie irrégulière au cours des trois à six premiers mois.
Certain side effects can occur in women who take HT. Forty percent of women undergoing HT treatment have irregular breakthrough bleeding during the first three to six months. In most cases bleeding stops within 12 months, but for some women it may continue beyond a year. Women taking estrogen therapy may experience breast tenderness, nausea, headache and bloating. These symptoms can often be treated by changing the dosage. HT may not mix well with certain other drugs. Any woman taking HT should consult a health-care provider about drug interactions.
  Hormonothérapie - menop...  
Certains effets indésirables peuvent se manifester chez les femmes qui prennent une HT. Quarante pour cent des femmes subissant un traitement à l’HT connaissent une métrorragie irrégulière au cours des trois à six premiers mois.
Certain side effects can occur in women who take HT. Forty percent of women undergoing HT treatment have irregular breakthrough bleeding during the first three to six months. In most cases bleeding stops within 12 months, but for some women it may continue beyond a year. Women taking estrogen therapy may experience breast tenderness, nausea, headache and bloating. These symptoms can often be treated by changing the dosage. HT may not mix well with certain other drugs. Any woman taking HT should consult a health-care provider about drug interactions.
  Hormonothérapie - menop...  
L’hormonothérapie (HT) est parfois prescrite pour rehausser le niveau d’hormones et offrir un certain soulagement. Comme l’hormonothérapie a fait l’objet d’une grande controverse, bon nombre de femmes se demandent si elle constitue une bonne option pour elle.
Hormone therapy (HT) is sometimes prescribed to boost hormone levels and provide relief. Because it has been the subject of some controversy, many women wonder if HT is a good option for them. The Menopause and Osteoporosis Update 2009 published by SOGC recommends that doctors prescribe HT in the lowest dose required, and for the duration necessary, to treat troubling menopause symptoms. Current research confirms that HT is both a safe and effective way to treat symptoms of menopause. Your health-care provider can help you understand the risks and benefits of different treatments.
  Ostéoporose - FAQ - mam...  
La Conférence canadienne de consensus de la SOGC ne recommande toutefois pas l’HT comme thérapie de première ligne pour l’ostéoporose, mais l’HT peut être recommandée pour certaines personnes présentant des symptômes de la ménopause.
Even short-term hormone therapy (HT) can improve a women’s bone structure, and then other medications can be used to sustain bone health over the longer-term. The Women’s Health Initiative in the United States, a randomized clinical trial involving menopausal women, found that hormone therapy was clearly effective in the prevention of hip fractures, vertebral breaks and other injuries. The SOGC Consensus Report, however, does not recommend HT as a first line therapy for osteoporosis, but HT may be recommended for certain individuals with the disease.
  Hormonothérapie - menop...  
L’HT combinée est associée à une baisse du risque de cancer colorectal et peut légèrement accroître le risque de cancer de l’ovaire. Ces effets sont faibles et ne devraient pas influencer la décision d’une femme quant à l’utilisation de l’HT.
Combined HT is associated with a reduced risk of colorectal cancer and may slightly increase the risk of ovarian cancer. These effects are rare and should not influence a woman’s decision about the use of HT. Women who have undergone a hysterectomy and no longer have a uterus are typically prescribed estrogen therapy (ET), while other women are more likely to be given EPT (a combination of estrogen and progestin). Progestin offers the added advantage of protecting the uterus’ lining from endometrial cancers. For women with premature ovarian failure, long-term HT can help manage certain health concerns.
  Hormonothérapie - menop...  
Quiconque ayant recours à l’hormonothérapie, surtout les femmes qui prennent le traitement depuis cinq ans ou plus, devraient consulter leur fournisseur de soins de santé tous les ans pour revoir le schéma posologique, les raisons pour lesquelles elles suivent une HT, ainsi que les risques et les avantages.
Anyone taking hormone therapy—especially women who have been taking the treatment for five years or more—should consult with their health-care provider each year to review dosage, reasons for taking HT, and risks and benefits. If you decide to stop treatment, your health-care provider can advise you how to do so safely.
  Hormonothérapie - menop...  
Quiconque ayant recours à l’hormonothérapie, surtout les femmes qui prennent le traitement depuis cinq ans ou plus, devraient consulter leur fournisseur de soins de santé tous les ans pour revoir le schéma posologique, les raisons pour lesquelles elles suivent une HT, ainsi que les risques et les avantages.
Anyone taking hormone therapy—especially women who have been taking the treatment for five years or more—should consult with their health-care provider each year to review dosage, reasons for taking HT, and risks and benefits. If you decide to stop treatment, your health-care provider can advise you how to do so safely.
  Ostéoporose - FAQ - mam...  
L’hormonothérapie (HT) est-elle ma première option si je sais que je souffre d’ostéoporose?
Is hormone therapy my first option if I know I have osteoporosis?
  Ostéoporose - FAQ - mam...  
L’hormonothérapie (HT) constitue-t-elle une option si j’ai des antécédents médicaux qui révèlent que je pourrais souffrir d’ostéoporose plus tard?
Is hormone therapy an option if I have a medical history that suggests that osteoporosis could be in my future?
  Mode de vie - FAQ - mam...  
On recommande aux femmes ayant recours à l’HT qui subissent une crise cardiaque, un accident vasculaire cérébral ou qui ont un caillot dans leurs veines (thrombo-embolie veineuse) de renoncer à l’hormonothérapie.
Women on hormone therapy (HT) who have a heart attack, a stroke or a blood clot in their veins (venous thromboembolism) are advised to discontinue hormone therapy.
  Santé de la vessie - FA...  
Parfois ce type d’incontinence peut être combiné à l’incontinence par impériosité. Les recherches courantes n’ont pas révélé que l’hormonothérapie (HT) améliore les conditions d’incontinence de manière considérable.
Sometimes this type of incontinence can be combined with urge incontinence. Current research has not proven that hormone therapy (HT) improves incontinence conditions in any significant way.
  Hormonothérapie - menop...  
Comment fonctionne l’HT?
How does HT work?
  Hormonothérapie - menop...  
Fiche d’information sur l’HT transdermique
Information Sheet on Transdermal HT
  Hormonothérapie - menop...  
La fluctuation ou la baisse des taux d’œstrogènes peut déclencher des migraines. Bien que ses effets varient, l’HT peut mener à une aggravation des migraines.
Fluctuating or decreasing levels of estrogen can trigger migraine headaches. Although the effects vary, HT can lead to a worsening of migraine headaches.
  Hormonothérapie - menop...  
L’utilisation à court terme de l’HT (jusqu’à concurrence de cinq ans) constitue une option sûre et efficace pour le traitement des symptômes ménopausiques allant de modérés à graves, tels que les bouffées de chaleur, les sueurs nocturnes les sautes d’humeur, l’insomnie, les troubles de la concentration et la sécheresse vaginale.
HT is a safe and effective option for short-term use (up to five years) for the treatment of moderate to severe menopausal symptoms such as hot flashes, night sweats, mood swings, insomnia, difficulty concentrating and vaginal dryness. In addition, HT has the secondary benefit of providing protection against osteoporosis and colon cancer.
  Hormonothérapie - menop...  
L’innocuité de l’HT
The safety of HT
1 2 3 4 5 Arrow